The Analyst Verdict: Enovix In The Eyes Of 8 Experts

During the last three months, 8 analysts shared their evaluations of Enovix ENVX, revealing diverse outlooks from bullish to bearish.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 4 3 1 0 0
Last 30D 0 1 0 0 0
1M Ago 2 2 1 0 0
2M Ago 2 0 0 0 0
3M Ago 0 0 0 0 0

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $22.62, with a high estimate of $36.00 and a low estimate of $14.00. This upward trend is apparent, with the current average reflecting a 6.25% increase from the previous average price target of $21.29.

price target chart

Interpreting Analyst Ratings: A Closer Look

An in-depth analysis of recent analyst actions unveils how financial experts perceive Enovix. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Colin Rusch Oppenheimer Maintains Outperform $36.00 $36.00
Alexander Potter Piper Sandler Lowers Overweight $19.00 $23.00
Gabe Daoud TD Cowen Raises Hold $14.00 $11.00
Derek Soderberg Cantor Fitzgerald Maintains Overweight $30.00 $30.00
Anthony Stoss Craig-Hallum Raises Buy $20.00 $15.00
George Gianarikas Canaccord Genuity Raises Buy $20.00 $17.00
Michael Legg Benchmark Announces Buy $25.00 -
George Gianarikas Canaccord Genuity Maintains Buy $17.00 $17.00

Key Insights:

  • Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Enovix. This information offers a snapshot of how analysts perceive the current state of the company.
  • Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Enovix compared to the broader market.
  • Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Enovix's stock. This examination reveals shifts in analysts' expectations over time.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Enovix's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Enovix analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Unveiling the Story Behind Enovix

Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.

Enovix's Economic Impact: An Analysis

Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.

Revenue Growth: Over the 3 months period, Enovix showcased positive performance, achieving a revenue growth rate of 8871.43% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.

Net Margin: Enovix's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -3075.16%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Enovix's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -58.0%, the company may face hurdles in generating optimal returns for shareholders.

Return on Assets (ROA): Enovix's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -23.22%, the company may face hurdles in achieving optimal financial performance.

Debt Management: Enovix's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.14, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

The Significance of Analyst Ratings Explained

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!